icon-folder.gif   Conference Reports for NATAP  
 
  ICAAC 2014 54th Interscience Conference
on Antimicrobial Agents and Chemotherapy
September 5-9, 2014, Washington, DC
Back grey_arrow_rt.gif
 
 
 
Once-Daily Doutegravir + Abacavir/Lamivudine is Superior to Efavirenz/Tenofovir/Emtricitabine in Treatment-Na´ve HIV Subjects: 144-Week Results - SINGLE Study (ING114467)
 
 
  Reported by Jules Levin
 
54th ICAAC Sept 5-9 2014, Washington DC
 
K Pappa, PharmD1, A Baumgartenm MD2, F Felizarta, MD3, E Florennce, MD4, J Portilla, MD5, SWalmsley, MD6, C Granier, DESS7, D Wong, MSc1, B Wynne, MD1

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif

ICAAC10.gif